Clinical Trials in Michigan

Showing 6541-6560 of 12,290 trials

Project IntERact Study

NCT03940716

This study will use a randomized control trial design (RCT) to pilot test a multisession remote therapy behavioral intervention for risky firearm behaviors and associated behaviors/consequences among adolescents. The study will pilot a state-of-the-art intervention delivery approaches (e.g., remote therapy, smartphone-based APP intervention content delivery) for reducing violence and associated behaviors among urban youth. Given the significant morality and mortality associated with firearm violence, the study will have significant impact by identifying optimal intervention strategies for future large-scale behavioral intervention trials.

ViolenceSubstance UseCriminal Behavior

University of Michigan15 participantsStarted May 2020

Flint, Michigan, United States

TERMINATEDPhase 348 miles

Study to Evaluate the Safety and Efficacy of Relamorelin in Participants With Diabetic Gastroparesis Study 02

NCT03426345

This study will evaluate the safety and efficacy of relamorelin compared to placebo in participants with diabetic gastroparesis. Participants will report daily severity scores of their diabetic gastroparesis symptoms.

GastroparesisDiabetes Mellitus

Allergan311 participantsStarted Feb 2018

Athens, Alabama, United States • Birmingham, Alabama, United States • Foley, Alabama, United States +237 more locations

Project IntERact Study

Study to Evaluate the Safety and Efficacy of Relamorelin in Participants With Diabetic Gastroparesis Study 02

Find Trials by Condition in Michigan

Evaluation of Geistlich Fibro-Gide® + CAF in Comparison to CTG + CAF for the Treatment of Recession Defects at 6 Months

A Study To Investigate Tanezumab In Patients With Interstitial Cystitis/ Painful Bladder Syndrome

Study of 18F-DCFPyL PET/CT Imaging in Patients With Prostate Cancer

Docetaxel and Carboplatin for Patients With mCRPC and DNA-Repair Deficiencies

rVWF IN PROPHYLAXIS

Varlitinib in Combination With Capecitabine for Advanced or Metastatic Biliary Tract Cancer

Open Label, Phase III Study of NABI-IGIV 10% [Immune Globulin Intravenous(Human), 10%] In Subjects With Primary Immune Deficiency Disorders (PIDD)

Study to Evaluate the Safety and Efficacy of JTE-051 in Subjects With Moderate to Severe Plaque Psoriasis

Study to Test the Safety, Tolerability and Efficacy of UCB7665 in Subjects With Moderate to Severe Myasthenia Gravis

Natural History of Rett Syndrome & Related Disorders

Biobanking of Rett Syndrome and Related Disorders

Telmisartan to Reduce AIDS-Related Fibrotic and Inflammatory Contributors (TRAFIC Study)

This is a Safety and Tolerability Study Evaluating a New Treatment for Subjects With Mild to Moderate Alzheimer's Disease

A Study of Prometic Plasminogen IV Infusion in Subjects With Hypoplasminogenemia

Safety and Efficacy of Sirolimus for HIV Reservoir Reduction in Individuals on Suppressive Antiretroviral Therapy (ART)

A Study of LY3295668 Erbumine in Participants With Extensive-stage Small-Cell Lung Cancer

Bioequivalence Study of PF-06651600 Capsules Relative to Tablets and Estimation of Food Effect on Capsules.

Tesetaxel Plus Reduced Dose of Capecitabine in Patients With HER2 Negative, HR Positive, LA/MBC